Method for detection and prevention of human cytomegalovirus inf

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 6, 435 91, 4351723, 435803, 536 27, 436 63, 436 94, 436501, 436504, 935 2, 935 10, 935 77, 935 78, C12Q 170, C12Q 168

Patent

active

050473204

ABSTRACT:
A DNA probe has been isolated which is capable of hybridizing to an oligonucleotide sequence coding for a polypeptide from a major 64 Kilodalton protein of human cytomegalovirus (HCMVgp64). The probe has a sequence of at least seventeen (17) to as many as seven hundred twenty-one (721) nucleotides. The probe may be labelled as by radioactivity. The probe has been used to screen DNA fragments constituting a subgenomic library of human cytomegalovirus DNA to obtain DNA fragments coding for the major late protein of human cytomegalovirus. The DNA fragments coding for the major late protein of human cytomegalovirus (HCMVgp64) may be hybridized to DNA fragments of HCMV DNA from an individual having human cytomegalovirus infection. The viral DNA can be used as whole HCMV DNA or as fragments formed by digesting the human cytomegalovirus DNA with a restriction endonuclease such as one of the restriction endonucleases EcoRI, BamHI, XbaI, HindIII and PrtI. During the screening of clinical specimens, the DNA fragment coding for HCMVgp64 of human cytomegalovirus hybridizes to whole HCMV DNA or to a particular one of the DNA fragments produced by digesting the human cytomegalovirus DNA with the restriction endonucleases. As a result of such hybridization, the identity of human cytomegalovirus may be established. The particular DNA fragment may have a map location of approximately 0.50 to 0.51 units in the human cytomegalovirus (strain Towne) genome. It may have a sequence of about 721 nucleotides. The major late protein of human cytomegalovirus (HCMVgp64) also reacts with T-lymphocytes of an individual after natural infection of that individual with human cytomegalovirus. Thus, the HCMVgp64 protein may a be used as a vaccine to prevent HCMV infection.

REFERENCES:
patent: 4358535 (1982-11-01), Falkow et al.
patent: 4762780 (1988-08-01), Spector et al.
Nowak, B. et al., Virology, 134, (Apr. 1984): 91-102.
Ruger, B. et al., J. Virology, 61, (Feb. 1987): 446-453.
Irmiere, A. et al., Virology, 130, (Oct. 1983): 118-133.
Pande, H. et al., Proc. Nat'l. Acad. Sci., USA, vol. 81, No. 15, 1984, pp. 4965-4969.
Clark, B. R. et al., J. Virology, vol. 49, No. 1, 1984, pp. 279-282.
Stinski, M. F. et al., J. Virology, vol. 46, No. 1, 1983, pp. 1-14.
Gelmann, E. P. et al., Proc. Nat'l. Acad. Sci. USA, vol. 80, 1983, pp. 5107-5111.
Fleckenstein, B. et al., Gene, vol. 18, 1982, pp. 39-46.
Tamashiro, J. C. et al., J. Virology, vol. 42, No. 2, 1982, pp. 547-557.
Spector S. A., The Lancet, Feb. 19, 1983, pp. 378-380.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for detection and prevention of human cytomegalovirus inf does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for detection and prevention of human cytomegalovirus inf, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detection and prevention of human cytomegalovirus inf will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-539429

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.